Ningbo David Medical Device (300314.SZ) subsidiary's products have obtained medical device registration certificate.
Dawei Medical (300314.SZ) announced that its wholly-owned subsidiary Ningbo Wellkady Medical Devices Co., Ltd....
Ningbo David Medical Device (300314.SZ) announced that its wholly-owned subsidiary Ningbo Weierkai Medical Devices Co., Ltd. ("Weierkai") recently received a "Medical Device Registration Certificate" issued by the Zhejiang Province Food and Drug Administration. The product is a disposable endoscope linear cutting stapler and components, which is used for closing the residual ends or incisions in laparoscopic digestive tract reconstruction and organ resection surgeries.
The disposable endoscope linear cutting stapler and components, registered this time by Weierkai, is an important instrument for laparoscopic surgery. It replaces traditional manual suturing and uses titanium staples to divide or close tissues. It has many advantages such as minimal surgical trauma, short operation time, and fast postoperative recovery. The laparoscopic stapler is increasingly being used in minimally invasive surgeries in general surgery, thoracic surgery, and other fields.
Related Articles

In the first three quarters, ordinary shareholders' profit attributable to ordinary shareholders of FE HORIZON (03360) increased year-on-year.

YH ENT (02306) spent HK$817,800 to repurchase 324,000 shares on October 21st.

Zhejiang Jingu(002488.SZ) will develop Avatar low-carbon vehicle wheel products for a certain German car company.
In the first three quarters, ordinary shareholders' profit attributable to ordinary shareholders of FE HORIZON (03360) increased year-on-year.

YH ENT (02306) spent HK$817,800 to repurchase 324,000 shares on October 21st.

Zhejiang Jingu(002488.SZ) will develop Avatar low-carbon vehicle wheel products for a certain German car company.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025